Sara Bandres-Ciga1,2, Sarah Ahmed1,3, Marya S Sabir1,3, Cornelis Blauwendraat1, Astrid D Adarmes-Gómez4,5, Inmaculada Bernal-Bernal4,5, Marta Bonilla-Toribio4,5, Dolores Buiza-Rueda4,5, Fátima Carrillo4,5, Mario Carrión-Claro4,5, Pilar Gómez-Garre4,5, Silvia Jesús4,5, Miguel A Labrador-Espinosa4,5, Daniel Macias4,5, Carlota Méndez-Del-Barrio4,5, Teresa Periñán-Tocino4,5, Cristina Tejera-Parrado4,5, Laura Vargas-González4,5, Monica Diez-Fairen6, Ignacio Alvarez6, Juan Pablo Tartari6, Mariateresa Buongiorno6, Miquel Aguilar6, Ana Gorostidi7,8,9, Jesús Alberto Bergareche7,8,10, Elisabet Mondragon7,8,10, Ana Vinagre-Aragon10, Ioana Croitoru7, Javier Ruiz-Martínez7,8,10, Oriol Dols-Icardo5,11, Jaime Kulisevsky5,12, Juan Marín-Lahoz5,12, Javier Pagonabarraga5,12, Berta Pascual-Sedano5,12, Mario Ezquerra5,13,14, Ana Cámara5,13,14, Yaroslau Compta5,13,14, Manel Fernández5,13,14, Rubén Fernández-Santiago5,13,14, Esteban Muñoz5,13,14, Eduard Tolosa5,13,14, Francesc Valldeoriola5,13,14, Isabel Gonzalez-Aramburu5,15, Antonio Sanchez Rodriguez5,15, María Sierra5,15, Manuel Menéndez-González16,17, Marta Blazquez16,17, Ciara Garcia16,17, Esther Suarez-San Martin16,17, Pedro García-Ruiz18, Juan Carlos Martínez-Castrillo19, Lydia Vela-Desojo20, Clara Ruz2,21, Francisco Javier Barrero2,22, Francisco Escamilla-Sevilla2,23, Adolfo Mínguez-Castellanos2,23, Debora Cerdan24, Cesar Tabernero24, Maria Jose Gomez Heredia25, Francisco Perez Errazquin25, Manolo Romero-Acebal25, Cici Feliz18, Jose Luis Lopez-Sendon19, Marina Mata26, Irene Martínez Torres27, Jonggeol Jeffrey Kim1, Clifton L Dalgard28,29, Janet Brooks1, Sara Saez-Atienzar30, J Raphael Gibbs31, Rafael Jorda32, Juan A Botia32,33, Luis Bonet-Ponce1, Karen E Morrison34, Carl Clarke35,36, Manuela Tan37, Huw Morris37, Connor Edsall1, Dena Hernandez1, Javier Simon-Sanchez38, Mike A Nalls1,39, Sonja W Scholz3,40, Adriano Jimenez-Escrig19, Jacinto Duarte24, Francisco Vives2,21, Raquel Duran2,21, Janet Hoenicka41,42, Victoria Alvarez17,43, Jon Infante5,15, Maria José Marti5,13,14, Jordi Clarimón5,11, Adolfo López de Munain7,8,44, Pau Pastor6, Pablo Mir4,5, Andrew Singleton1. 1. Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA. 2. Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Granada, Spain. 3. Neurodegenerative Diseases Research Unit, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA. 4. Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Seville, Spain. 5. Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Spain. 6. Fundació Docència i Recerca Mútua de Terrassa and Movement Disorders Unit, Department of Neurology, University Hospital Mútua de Terrassa, Terrassa, Barcelona, Spain. 7. Neurodegenerative Disorders Area, Biodonostia Health Research Institute, San Sebastián, Spain. 8. Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Madrid, Spain. 9. Plataforma de Genomica, Instituto de Investigacion Biodonostia, San Sebastián, Spain. 10. Unidad de Trastornos de Movimiento, Departamento de Neurologia, Hospital Universitario de Donostia, San Sebastián, Spain. 11. Genetics of Neurodegenerative Disorders Unit, IIB Sant Pau, and Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain. 12. Movement Disorders Unit, Neurology Department, Sant Pau Hospital, Universitat Autònoma de Barcelona, Barcelona, Catalonia, Spain. 13. Lab. of Parkinson disease and Other Neurodegenerative Movement Disorders, IDIBAPS-Institut d'Investigacions Biomèdiques, Barcelona, Catalonia, Spain. 14. Unitat de Parkinson i Trastorns del Moviment. Servicio de Neurologia, Hospital Clínic de Barcelona and Institut de Neurociencies de la Universitat de Barcelona (Maria de Maetzu Center), Catalonia, Spain. 15. Servicio de Neurología, Hospital Universitario Marqués de Valdecilla (IDIVAL) and Universidad de Cantabria, Santander, Spain. 16. Servicio de Neurología, Hospital Universitario Central de Asturias, Asturias, Spain. 17. Instituto de Investigación Sanitaria del Principado de Asturias (ISPA), Asturias, Spain. 18. Departamento de Neurologia, Instituto de Investigación Sanitaria Fundación Jiménez Díaz, Madrid, Spain. 19. Departamento de Neurologia, Instituto Ramón y Cajal de Investigación Sanitaria, Hospital Universitario Ramón y Cajal, Madrid, Spain. 20. Servicio de Neurologia, Hospital Universitario Fundación Alcorcón, Madrid, Spain. 21. Centro de Investigacion Biomedica and Departamento de Fisiologia, Facultad de Medicina, Universidad de Granada, Granada, Spain. 22. Servicio de Neurología, Hospital Universitario San Cecilio, Granada, Universidad de Granada, Spain. 23. Servicio de Neurología, Hospital Universitario Virgen de las Nieves, Granada, Spain. 24. Servicio de Neurología, Hospital General de Segovia, Segovia, Spain. 25. Servicio de Neurología, Hospital Universitario Virgen de la Victoria, Malaga, Spain. 26. Departamento de Neurologia, Hospital Universitario Infanta Sofía, Madrid, Spain. 27. Departamento de Neurologia, Instituto de Investigación Sanitaria La Fe, Hospital Universitario y Politécnico La Fe, Valencia, Spain. 28. Department of Anatomy, Physiology & Genetics, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA. 29. The American Genome Center, Collaborative Health Initiative Research Program, Uniformed Services University of the Health Sciences, Bethesda, Maryland, USA. 30. Neuromuscular Diseases Research Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA. 31. Computational Biology Group, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA. 32. Departamento de Ingeniería de la Información y las Comunicaciones, Universidad de Murcia, Murcia, Spain. 33. Department of Molecular Neuroscience, UCL, Institute of Neurology, London, United Kingdom. 34. Department of Neurology, Faculty of Medicine, University of Southampton, Southampton, United Kingdom. 35. University of Birmingham, Birmingham, United Kingdom. 36. Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, United Kingdom. 37. Department of Clinical Neuroscience, University College London, London, United Kingdom. 38. Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, and DZNE, German Center for Neurodegenerative Diseases, Tübingen, Germany. 39. Data Tecnica International, Glen Echo, Maryland, USA. 40. Department of Neurology, Johns Hopkins Medical Center, Baltimore, Maryland, USA. 41. Laboratorio de Neurogenética y Medicina Molecular, Institut de Recerca Sant Joan de Déu, Barcelona, Spain. 42. Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Madrid, Spain. 43. Laboratorio de Genética, Hospital Universitario Central de Asturias, Asturias, Spain. 44. Departamento de Neurociencias. UPV-EHU, Servicio de Neurología, Hospital Universitario Donostia, San Sebastián, Spain.
Abstract
BACKGROUND: The Iberian Peninsula stands out as having variable levels of population admixture and isolation, making Spain an interesting setting for studying the genetic architecture of neurodegenerative diseases. OBJECTIVES: To perform the largest PD genome-wide association study restricted to a single country. METHODS: We performed a GWAS for both risk of PD and age at onset in 7,849 Spanish individuals. Further analyses included population-specific risk haplotype assessments, polygenic risk scoring through machine learning, Mendelian randomization of expression, and methylation data to gain insight into disease-associated loci, heritability estimates, genetic correlations, and burden analyses. RESULTS: We identified a novel population-specific genome-wide association study signal at PARK2 associated with age at onset, which was likely dependent on the c.155delA mutation. We replicated four genome-wide independent signals associated with PD risk, including SNCA, LRRK2, KANSL1/MAPT, and HLA-DQB1. A significant trend for smaller risk haplotypes at known loci was found compared to similar studies of non-Spanish origin. Seventeen PD-related genes showed functional consequence by two-sample Mendelian randomization in expression and methylation data sets. Long runs of homozygosity at 28 known genes/loci were found to be enriched in cases versus controls. CONCLUSIONS: Our data demonstrate the utility of the Spanish risk haplotype substructure for future fine-mapping efforts, showing how leveraging unique and diverse population histories can benefit genetic studies of complex diseases. The present study points to PARK2 as a major hallmark of PD etiology in Spain.
BACKGROUND: The Iberian Peninsula stands out as having variable levels of population admixture and isolation, making Spain an interesting setting for studying the genetic architecture of neurodegenerative diseases. OBJECTIVES: To perform the largest PD genome-wide association study restricted to a single country. METHODS: We performed a GWAS for both risk of PD and age at onset in 7,849 Spanish individuals. Further analyses included population-specific risk haplotype assessments, polygenic risk scoring through machine learning, Mendelian randomization of expression, and methylation data to gain insight into disease-associated loci, heritability estimates, genetic correlations, and burden analyses. RESULTS: We identified a novel population-specific genome-wide association study signal at PARK2 associated with age at onset, which was likely dependent on the c.155delA mutation. We replicated four genome-wide independent signals associated with PD risk, including SNCA, LRRK2, KANSL1/MAPT, and HLA-DQB1. A significant trend for smaller risk haplotypes at known loci was found compared to similar studies of non-Spanish origin. Seventeen PD-related genes showed functional consequence by two-sample Mendelian randomization in expression and methylation data sets. Long runs of homozygosity at 28 known genes/loci were found to be enriched in cases versus controls. CONCLUSIONS: Our data demonstrate the utility of the Spanish risk haplotype substructure for future fine-mapping efforts, showing how leveraging unique and diverse population histories can benefit genetic studies of complex diseases. The present study points to PARK2 as a major hallmark of PD etiology in Spain.
Authors: Stacey B Gabriel; Stephen F Schaffner; Huy Nguyen; Jamie M Moore; Jessica Roy; Brendan Blumenstiel; John Higgins; Matthew DeFelice; Amy Lochner; Maura Faggart; Shau Neen Liu-Cordero; Charles Rotimi; Adebowale Adeyemo; Richard Cooper; Ryk Ward; Eric S Lander; Mark J Daly; David Altshuler Journal: Science Date: 2002-05-23 Impact factor: 47.728
Authors: Sara Bandrés-Ciga; Niccolò Emmanuele Mencacci; Raquel Durán; Francisco Javier Barrero; Francisco Escamilla-Sevilla; Sarah Morgan; Jason Hehir; Francisco Vives; John Hardy; Alan M Pittman Journal: Neurobiol Aging Date: 2015-10-08 Impact factor: 4.673
Authors: Zhihong Zhu; Futao Zhang; Han Hu; Andrew Bakshi; Matthew R Robinson; Joseph E Powell; Grant W Montgomery; Michael E Goddard; Naomi R Wray; Peter M Visscher; Jian Yang Journal: Nat Genet Date: 2016-03-28 Impact factor: 38.330
Authors: E Muñoz; E Tolosa; P Pastor; M J Martí; F Valldeoriola; J Campdelacreu; R Oliva Journal: J Neurol Neurosurg Psychiatry Date: 2002-11 Impact factor: 10.154
Authors: Harm-Jan Westra; Marjolein J Peters; Tõnu Esko; Hanieh Yaghootkar; Claudia Schurmann; Johannes Kettunen; Mark W Christiansen; Bruce M Psaty; Samuli Ripatti; Alexander Teumer; Timothy M Frayling; Andres Metspalu; Joyce B J van Meurs; Lude Franke; Benjamin P Fairfax; Katharina Schramm; Joseph E Powell; Alexandra Zhernakova; Daria V Zhernakova; Jan H Veldink; Leonard H Van den Berg; Juha Karjalainen; Sebo Withoff; André G Uitterlinden; Albert Hofman; Fernando Rivadeneira; Peter A C 't Hoen; Eva Reinmaa; Krista Fischer; Mari Nelis; Lili Milani; David Melzer; Luigi Ferrucci; Andrew B Singleton; Dena G Hernandez; Michael A Nalls; Georg Homuth; Matthias Nauck; Dörte Radke; Uwe Völker; Markus Perola; Veikko Salomaa; Jennifer Brody; Astrid Suchy-Dicey; Sina A Gharib; Daniel A Enquobahrie; Thomas Lumley; Grant W Montgomery; Seiko Makino; Holger Prokisch; Christian Herder; Michael Roden; Harald Grallert; Thomas Meitinger; Konstantin Strauch; Yang Li; Ritsert C Jansen; Peter M Visscher; Julian C Knight Journal: Nat Genet Date: 2013-09-08 Impact factor: 38.330
Authors: William Zhu; Xiaoping Huang; Esther Yoon; Sara Bandres-Ciga; Cornelis Blauwendraat; Kimberly J Billingsley; Joshua H Cade; Beverly P Wu; Victoria H Williams; Alice B Schindler; Janet Brooks; J Raphael Gibbs; Dena G Hernandez; Debra Ehrlich; Andrew B Singleton; Derek P Narendra Journal: Brain Date: 2022-06-30 Impact factor: 15.255
Authors: Kathryn R Bowles; Derian A Pugh; Yiyuan Liu; Tulsi Patel; Alan E Renton; Sara Bandres-Ciga; Ziv Gan-Or; Peter Heutink; Ari Siitonen; Sarah Bertelsen; Jonathan D Cherry; Celeste M Karch; Steven J Frucht; Brian H Kopell; Inga Peter; Y J Park; Alexander Charney; Towfique Raj; John F Crary; A M Goate Journal: Mol Neurodegener Date: 2022-07-15 Impact factor: 18.879